BackgroundCheck.run
Search For

Paul Allen Finnegan, 65200 Ethelrob Cir, Carlisle, OH 45005

Known as:
Paul A Finnegan
Related to:
Jeffrey J Johnston 62 Gregory J Taylor 58

Paul Finnegan Phones & Addresses

200 Ethelrob Cir, Franklin, OH 45005    513-5452758   

Carlisle, OH   

12015 Oak St, Loveland, OH 45140    513-6832969   

930 Addor St, Port Hueneme, CA 93041    805-4868789   

San Diego, CA   

Pensacola, FL   

Imperial Beach, CA   

Delaware, OH   

Fostoria, IA   

Get Report
Control this profile

Mentions for Paul Allen Finnegan

Career records & work history

Lawyers & Attorneys

Paul Finnegan Photo 1

Paul Finnegan - Lawyer

Specialties:
Executive Compensation, Employee Benefits, ERISA, Estate Planning
ISLN:
907422233
Admitted:
1966
University:
College of the Holy Cross, A.B., 1963
Law School:
Boston College, LL.B., 1966

Paul Finnegan resumes & CV records

Resumes

Paul Finnegan Photo 55

Paul Finnegan

Location:
United States
Industry:
Information Technology and Services
Paul Finnegan Photo 56

Paul Finnegan

Location:
United States
Paul Finnegan Photo 57

Paul Finnegan

Location:
United States
Paul Finnegan Photo 58

Paul Finnegan

Location:
United States

Publications & IP owners

Us Patents

Compositions And Methods For Thymic Regeneration And T-Cell Reconstitution

US Patent:
2022022, Jul 21, 2022
Filed:
May 28, 2020
Appl. No.:
17/614521
Inventors:
- San Diego CA, US
Karolina Kucharova - San Diego CA, US
Michael Daniel Ginsberg - San Diego CA, US
Daniel Joseph Nolan - Hawthorne NY, US
Paul William Finnegan - Del Mar CA, US
International Classification:
A61K 35/44
C12N 5/071
C12N 15/63
Abstract:
The present invention provides non-thymic endothelial cells (ntECs) engineered to express adenovirus E4ORF1 and/or BMP4, and compositions comprising such engineered ntECs. The present invention also provides methods of using such ntECs in therapy, for example to enhance thymic regeneration (including T cell reconstitution) in subjects in need thereof. Such subjects include those that have a damaged thymus, defective thymic function, insufficient T-cell output, and/or that are immunocompromised—for example as a result of ageing, infection (e.g. with HIV), treatment with radiation therapy, treatment with chemotherapy, or myeloablative conditioning in preparation for an organ/tissue transplant.

Engineered Endothelial Cells Expressing An Ets Transcription Factor

US Patent:
2022020, Jun 30, 2022
Filed:
Mar 7, 2021
Appl. No.:
17/194293
Inventors:
- San Diego CA, US
Paul William Finnegan - Del Mar CA, US
Michael Daniel Ginsberg - San Diego CA, US
Claude Geoffrey Davis - Auburn CA, US
International Classification:
C12N 5/071
A61K 38/16
A61K 38/17
A61K 35/44
A61K 35/28
C07K 14/005
C07K 14/47
C12N 5/0789
C12N 7/00
C12N 15/86
Abstract:
In some aspects the present invention relates to engineered endothelial cells, such as E4ORF1+ ETV2+ engineered endothelial cells. In other aspects the present invention relates to methods of making such engineered endothelial cells, and methods of using such engineered endothelial cells, for example in co-culture applications.

Engineered Endothelial Cells Expressing An Ets Transcription Factor

US Patent:
2018019, Jul 12, 2018
Filed:
Jul 19, 2016
Appl. No.:
15/746397
Inventors:
- San Diego CA, US
Paul William Finnegan - Del Mar CA, US
Michael Daniel Ginsberg - San Diego CA, US
Claude Geoffrey Davis - Auburn CA, US
International Classification:
C12N 5/071
C07K 14/47
C07K 14/005
C12N 7/00
C12N 15/86
C12N 5/0789
A61K 35/44
A61K 35/28
A61K 38/17
A61K 38/16
Abstract:
In some aspects the present invention relates to engineered endothelial cells, such as E40RF1+ ETV2+ engineered endothelial cells. In other aspects the present invention relates to methods of making such engineered endothelial cells, and methods of using such engineered endothelial cells, for example in co-culture applications.

Uses Of Humanized Cobra Venom Factor For Reducing Or Preventing Immunogenicity

US Patent:
2017012, May 11, 2017
Filed:
Jun 12, 2015
Appl. No.:
15/318311
Inventors:
- Honolulu HI, US
Paul FINNEGAN - Del Mar CA, US
Julie RAYES - Paris, FR
Sebastien LACROIX-DESMAZES - Paris, FR
International Classification:
A61K 38/37
C07K 16/28
C07K 16/30
A61K 38/17
Abstract:
The embodiments herein are concerned with methods and hCVF compositions, including pharmaceutical formulations, useful in complement depletion, the reduction or prevention of unwanted immunogenicity or other immune-related reactions, especially as a consequence of administering a biologic therapy. Such methods and compositions have been found to be effective in complement depletion during more than one administration in the same subject, thereby being useful for prolonged/repeated use.

Amazon

Paul Finnegan Photo 63

Who Owns Marriage?: A Conversation About Religion, Government, Marriage And A Civil Society

Author:
Nick Park, Patrick Mitchel, Michael Nugent, Sean Mullan, Kirsty Park, Richard Carson, David Quinn, Brian Finnegan, Paul Moynan
Publisher:
Success Services Ireland
Binding:
Kindle Edition
Pages:
140
A conversation among Christians and others that goes beyond the controversy of Ireland's Same-Sex Marriage Referendum and looks at the big questions of marriage, sexuality, identity, and how people in a secular society can be true to their beliefs while still respecting each other.

Possible Relatives

Cynthia Finnegan  David D Finnegan  Davy J Finnegan  Debbie L Finnegan  Deborah Finnegan  Dana M Finnegan  Debra D Finnegan  Paul M Johnson  Paul Stamps  Paul B Stanaway 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.